Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

322.00p
   
  • Change Today:
      2.00p
  • 52 Week High: 470.00p
  • 52 Week Low: 166.80p
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 220,204
  • Market Cap: £322.00m
  • RiskGrade: 125

Oxford Biomedica, AstraZeneca extend Covid vaccine deal

By Frank Prenesti

Date: Tuesday 01 Sep 2020

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica said it had extended its agreement with AstraZeneca to mass-produce its Covid-19 vaccine candidate.
The company said AstraZeneca would give it $15m upfront to procure manufacturing capacity at its plant and that it could get an additional $35m plus other costs until the end of 2021 under the new 18-month deal.

AstraZeneca's vaccine candidate, known as AZD1222, has moved to late stage trials in the US. Oxford Biomedica said the deal announced on Tuesday could be further expanded by 18 months.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 322.00p
Change Today 2.00p
% Change 0.63 %
52 Week High 470.00p
52 Week Low 166.80p
Volume 220,204
Shares Issued 100.00m
Market Cap £322.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.86% below the market average26.86% below the market average26.86% below the market average26.86% below the market average26.86% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average
51.85% above the sector average51.85% above the sector average51.85% above the sector average51.85% above the sector average51.85% above the sector average
Income Not Available
Growth
52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 15-May-2024

Time Volume / Share Price
16:35 25,047 @ 322.00p
16:35 87 @ 322.00p
16:35 36 @ 322.00p
16:35 36 @ 322.00p
16:35 22 @ 322.00p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page